KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Progyny (PGNY) Shares Outstanding (2018 - 2025)

Progyny (PGNY) has disclosed Shares Outstanding for 8 consecutive years, with $99.0 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 16.1% to $99.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $99.0 million through Dec 2025, up 16.1% year-over-year, with the annual reading at $99.0 million for FY2025, 16.1% up from the prior year.
  • Shares Outstanding for Q4 2025 was $83.4 million at Progyny, down from $86.1 million in the prior quarter.
  • The five-year high for Shares Outstanding was $85.9 billion in Q2 2025, with the low at $83.4 million in Q4 2025.
  • Average Shares Outstanding over 5 years is $4.4 billion, with a median of $91.4 million recorded in 2021.
  • The sharpest move saw Shares Outstanding fell 11.46% in 2024, then surged 94626.24% in 2025.
  • Over 5 years, Shares Outstanding stood at $91.1 million in 2021, then increased by 2.43% to $93.3 million in 2022, then grew by 3.27% to $96.3 million in 2023, then fell by 11.46% to $85.3 million in 2024, then grew by 16.1% to $99.0 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $99.0 million, $86.1 million, and $85.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.